MicroPort Endovascular MedTech Affiliates Get China Nod for Blood Vessel Repair Devices

MT Newswires Live2024-09-24

China's medical products administrator approved Shanghai MicroPort Endovascular MedTech's (SHA:688016) medical device registration for its fiber hair embolic coils, according to a Tuesday filing with the Shanghai Stock Exchange.

Fiber hair embolic coils pack peripheral vascular aneurysms, arteriovenous malformations or abnormalities between arteries and veins in brain and spinal cord tissue, and arteriovenous fistulas or connections in the coverings of the brain or spinal cord.

The regulator also accepted MicroPort Endovascular agent Veryan Medical's medical device registration for its peripheral stent system, which improves the lumen diameter of primary lesions in arteries, the filing said.

Shares closed 5% higher in Shanghai during Tuesday's trading.

Price (RMB): ¥84.12, Change: ¥+4.3, Percent Change: +5.40%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment